| Dr James R Colvert Iii, MD | |
|
615 E Oklahoma Ave, Ste 202, Enid, OK 73701-5952 | |
| (580) 233-3230 | |
| (580) 233-0698 |
| Full Name | Dr James R Colvert Iii |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 26 Years |
| Location | 615 E Oklahoma Ave, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194727461 | NPI | - | NPPES |
| P000052000 | Other | OK | RAILROAD M/C |
| 200015940A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 21222 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Share Medical Center | Alva, OK | Hospital |
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Fairview Regional Medical Center Authority | Fairview, OK | Hospital |
| Ponca City Medical Center | Ponca city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Enid Urology Associates, Inc. | 6305828211 | 3 |
News Archive
The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system.
A member of the Scleroderma Foundation's Board of Directors has led a team of researchers who have identified a peptide that can block fibrosis of the skin and lungs, according to a report published today.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate - a previously unknown circumstance with ramifications for how tumour cells respond to treatment.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
› Verified 3 days ago
| Entity Name | Enid Urology Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942301916 PECOS PAC ID: 6305828211 Enrollment ID: O20040603001408 |
News Archive
The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system.
A member of the Scleroderma Foundation's Board of Directors has led a team of researchers who have identified a peptide that can block fibrosis of the skin and lungs, according to a report published today.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate - a previously unknown circumstance with ramifications for how tumour cells respond to treatment.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James R Colvert Iii, MD 615 E Oklahoma Ave, Ste 202, Enid, OK 73701-5952 Ph: (580) 233-3230 | Dr James R Colvert Iii, MD 615 E Oklahoma Ave, Ste 202, Enid, OK 73701-5952 Ph: (580) 233-3230 |
News Archive
The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system.
A member of the Scleroderma Foundation's Board of Directors has led a team of researchers who have identified a peptide that can block fibrosis of the skin and lungs, according to a report published today.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate - a previously unknown circumstance with ramifications for how tumour cells respond to treatment.
Neurotechnology, a provider of high-precision biometric identification technologies, today announced their new line of embedded biometric technologies, including VeriFinger Embedded SDK for fingerprint biometrics, VeriLook Embedded SDK for face biometrics and MegaMatcher Embedded SDK for multi-biometric systems using face and fingerprints in combination.
› Verified 3 days ago
Dr. Rodney L Worthen Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 615 E. Oklahoma Ave., Ste 202, Enid, OK 73701 Phone: 580-233-3230 Fax: 580-233-0698 | |
Jerry B Blankenship, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1220 W Willow Rd, Ste A, Enid, OK 73703 Phone: 580-234-6200 | |
Dr. Jarrett D Kruska, M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 615 E Oklahoma Ave, Ste 202, Enid, OK 73701 Phone: 580-233-3230 Fax: 580-233-0698 | |
Robert C Hoffman, M.D Urology Medicare: Not Enrolled in Medicare Practice Location: 615 E Oklahoma Ave, Ste 202, Enid, OK 73701 Phone: 580-233-3230 Fax: 580-233-0698 |